Nevertheless, epigenomic profiling technologies may help identify the mechanisms by which specific HDAC subunits act upon complexes and downstream targets to bring about epigenetic changes in gene expression relevant to the therapeutics of mood disorders. The gene discussed is HDAC9; the disease is mood disorder.